ArticleCardiovascular diabetology. Endocrinology reports2025
Metabolic syndrome and associated factors among benign prostatic hyperplasia patients at Jimma University Medical center, Jimma, Southwest Ethiopia.
Article in Cardiovascular diabetology. Endocrinology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- The Association Between Metabolic Syndrome and Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis.American journal of men's healthPooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBenign prostatic hyperplasia (BPH) involves the enlargement of epithelial and stromal cells of the prostate gland. Its prevalence is increasing owing in part to the rising rate of metabolic syndrome, which includes dyslipidemia, hypertension, hyperinsulinemia, and central obesity. Despite this trend, there is a paucity of data on BPH and metabolic syndrome in the Ethiopian population. This study aims to assess the prevalence and factors associated with metabolic syndrome among BPH patients in southwestern Ethiopia. MATERIALS AND
methodsA hospital-based cross-sectional study was conducted with 158 BPH patients at Jimma University Medical Center (JUMC) from January 15 to April 15, 2024. Socio-demographic data were collected via a WHO stepwise questionnaire and trained nurses collected 5 ml fasting blood samples. The samples were consequently analyzed by trained laboratory technologists at JUMC.
resultsThe overall prevalence of metabolic syndrome among BPH patients was 38.6% (95% CI: 0.31,0.46). There were significant associations between factors such as age (AOR = 3.43, CI: 1.3, 9), residence (AOR = 3.35, CI:1.35,8.30), total cholesterol (AOR = 3.2, CI: 1.27,8.06), low LDL levels (AOR = 3.54, CI:1.08, 11.5 hyperuricemia (AOR = 3.21, CI:1.02,10.01), BMI (AOR = 3.47, CI:1.44,8.32), waist-to-hip ratio (WHR) (AOR = 5.07, CI:2.15,11.98), and metabolic syndrome.
conclusionThe prevalence of metabolic syndrome among patients with BPH is notably high. The authors recommend the need for early assessment of risk factors and timely intervention to prevent potential complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.